Resources

Fenofibrate in combination with coenzyme Q10 (CoQ) appears to have a number of beneficial effects in type 2 diabetic subjects with mild left ventricular (LV) diastolic dysfunction, researchers report.

According to findings from a Swedish study, the risk of non-traumatic lower-extremity amputation remains high among patients with type 1 diabetes.

A snapshot of the retina could detect cell damage in the early stages of diabetes. Diabetics can lose “a substantial fraction–up to 50 percent–of their retinal cells” before they’re aware of vision problems.

Aggressive diabetes risk management appears to have lessened the rate of stroke and mortality for the first time for these patients, researchers found.

When given to mice the protein increases the production of brown fat cells – which burn calories. The discovery could lead to the development of new therapies for tackling obesity.

According to the FDA, within the last year, six cases of hemorrhagic or necrotizing pancreatitis have been reported in patients taking exenatide for type 2 diabetes.

Certain mild neurologic findings in childhood are associated with adult obesity, according to the results of a longitudinal birth cohort study. Possible way to predict future risk for diabetes?

Magnetic resonance imaging (MRI) isn’t just for capturing detailed images of the body’s anatomy. Thanks to novel imaging reagents and technology, MRI can be used to visualize — with “exquisite” specificity — cell populations of interest in the living body.

Australian researchers said that they had developed a drug which could potentially spell an end to a life-threatening condition caused by diabetes, heart disease and other illnesses.

People who use monosodium glutamate, or MSG, as a flavor enhancer in their food are more likely than people who don’t use it to be overweight or obese even though they have the same amount of physical activity and total calorie intake, according to a study published this month in …